Advertisement Kinase Inhibition - New Chemotypes for p38 MAP Kinase - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Kinase Inhibition – New Chemotypes for p38 MAP Kinase

CASE STUDIES
By

p38 mitogen-activated protein kinase (MAPK) has a vital role in the production of pro-inflammatory cytokines such as TNF-α and IL-1β. The inhibition of this enzyme has potential therapeutic value against overactive immune responses associated with rheumatoid arthritis, psoriasis, multiple sclerosis and inflammatory bowel diseases.
Please click here.

To view the full case study please click here.

Quick Contact


Top Products from